API
< Back to situations

[ORGANIZATION]

GlaxoSmithKline

Featured in 15 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [IT] [US]

Italy influenza, COVID-19 and RSV vaccination rollout

33 clusters · 258 sources · last updated

Latest: Italy influenza vaccination campaign and respiratory virus trends

The 2026-2027 seasonal vaccination campaign in Italy, targeting influenza, COVID-19, and Respiratory Syncytial Virus (RSV), is underway. While some regions report growth, others face logistical and supply challenges. In

[ACTIVE] [BUSINESS] [EG] [KW] [QA]

Egyptian market volatility follows record capitalisation

18 clusters · 21 sources · last updated

Latest: Egyptian stock market indices rise during early Sunday trading

Following a period of institutional selling in late September, the Egyptian Exchange experienced continued volatility. On September 29, the benchmark EGX30 fell 0.33% to close at 52,297 points. Although an intraday recov

[QUIET] [BUSINESS] [IT]

Italian health and insurance economic sectors

2 clusters · 55 sources · last updated

Latest: Italy health and food sectors face economic and demographic shifts

The Italian insurance market experienced growth in 2025, with total premiums reaching 182 billion euros, a 7.8% increase from the previous year. Data from ANIA indicates the non-life sector rose by 6.5%, influenced by ri

[QUIET] [BUSINESS] [CN] [IN] [JP]

Global vaccine market growth and technology trends

2 clusters · 5 sources · last updated

Latest: Japan industrial robotics market projected to reach $3.18 billion by 2035

The global vaccine sector is experiencing significant growth across different segments. The vaccine delivery device market is projected to expand from $8.1 billion in 2025 to $17.1 billion by 2035, driven by immunization

Also covered in